Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-115729
Filing Date
2024-10-18
Accepted
2024-10-18 20:08:18
Documents
1
Period of Report
2024-10-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 8257
  Complete submission text file 0000950170-24-115729.txt   9680
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Issuer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O AURA BIOSCIENCES, INC. 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address
de los Pinos Elisabet (Reporting) CIK: 0001889633 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40971 | Film No.: 241381742